Clinical trial
Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease. A Cross-sectional Multi-centre Clinical Study in Subjects With Cardiovascular Disease Risk Factors.
NCT00928629 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease. A Cross-sectional Multi-centre Clinical Study in Subjects With Cardiovascular Disease Risk Factors.
- Lead sponsor
- AstraZeneca
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2009
- Completion date
- October 31, 2009
- Enrollment
- 1,000 (estimated)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.